Selected research
Market Outlook & Growth Opportunities
Global Large-Scale Oligonucleotide Synthesis Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Large-Scale Oligonucleotide Synthesis Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Large-Scale Oligonucleotide Synthesis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Large-Scale Oligonucleotide Synthesis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Large-Scale Oligonucleotide Synthesis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Large-Scale Oligonucleotide Synthesis Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Large-Scale Oligonucleotide Synthesis Services market include Thermo Fisher Scientific, Merck, Genscript, Guangzhou RiboBio, Tsingke, Abace Biotechnology, TriLink BioTechnologies, Synbio Technologies and Macrogen, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Large-Scale Oligonucleotide Synthesis Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Large-Scale Oligonucleotide Synthesis Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Large-Scale Oligonucleotide Synthesis Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Large-Scale Oligonucleotide Synthesis Services market.
Large-Scale Oligonucleotide Synthesis Services Segment by Company
Thermo Fisher Scientific
Merck
Genscript
Guangzhou RiboBio
Tsingke
Abace Biotechnology
TriLink BioTechnologies
Synbio Technologies
Macrogen
Integrated DNA Technologies (IDT)
Eurogentec
Cusabio
BBI Life Sciences
Azenta Life Sciences
Aurigene Pharmaceutical Services
Large-Scale Oligonucleotide Synthesis Services Segment by Type
Common Primer Synthesis
Modified Primer Synthesis
Large-Scale Oligonucleotide Synthesis Services Segment by Application
Biotech Company
Academic Scientific Research Institution
Large-Scale Oligonucleotide Synthesis Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Large-Scale Oligonucleotide Synthesis Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Large-Scale Oligonucleotide Synthesis Services key companies, revenue, market share, and recent developments.
3. To split the Large-Scale Oligonucleotide Synthesis Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Large-Scale Oligonucleotide Synthesis Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Large-Scale Oligonucleotide Synthesis Services significant trends, drivers, influence factors in global and regions.
6. To analyze Large-Scale Oligonucleotide Synthesis Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Large-Scale Oligonucleotide Synthesis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Large-Scale Oligonucleotide Synthesis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Large-Scale Oligonucleotide Synthesis Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Large-Scale Oligonucleotide Synthesis Services industry.
Chapter 3: Detailed analysis of Large-Scale Oligonucleotide Synthesis Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Large-Scale Oligonucleotide Synthesis Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Large-Scale Oligonucleotide Synthesis Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Large-Scale Oligonucleotide Synthesis Services Industry Trends
Table 2. Large-Scale Oligonucleotide Synthesis Services Industry Drivers
Table 3. Large-Scale Oligonucleotide Synthesis Services Industry Opportunities and Challenges
Table 4. Large-Scale Oligonucleotide Synthesis Services Industry Restraints
Table 5. Global Large-Scale Oligonucleotide Synthesis Services Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Large-Scale Oligonucleotide Synthesis Services Revenue Share by Company (2021-2026)
Table 7. Global Large-Scale Oligonucleotide Synthesis Services Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Large-Scale Oligonucleotide Synthesis Services Key Company Manufacturing Base & Headquarters
Table 9. Global Large-Scale Oligonucleotide Synthesis Services Company, Product Type & Application
Table 10. Global Large-Scale Oligonucleotide Synthesis Services Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Large-Scale Oligonucleotide Synthesis Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Common Primer Synthesis
Table 15. Significant Companies of Modified Primer Synthesis
Table 16. Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 17. Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Type (2021-2026) & (US$ Million)
Table 18. Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Type (2027-2032) & (US$ Million)
Table 19. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type (2021-2026)
Table 20. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type (2027-2032)
Table 21. Significant Companies of Biotech Company
Table 22. Significant Companies of Academic Scientific Research Institution
Table 23. Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 24. Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Application (2021-2026) & (US$ Million)
Table 25. Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Application (2027-2032) & (US$ Million)
Table 26. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application (2021-2026)
Table 27. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application (2027-2032)
Table 28. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 29. Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Region (2021-2026) & (US$ Million)
Table 30. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Region (2021-2026)
Table 31. Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Region (2027-2032) & (US$ Million)
Table 32. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Region (2027-2032)
Table 33. Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Country (2021-2026) & (US$ Million)
Table 35. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Market Share by Country (2021-2026)
Table 36. Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Country (2027-2032) & (US$ Million)
Table 37. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Market Share by Country (2027-2032)
Table 38. Thermo Fisher Scientific Company Information
Table 39. Thermo Fisher Scientific Business Overview
Table 40. Thermo Fisher Scientific Large-Scale Oligonucleotide Synthesis Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 41. Thermo Fisher Scientific Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 42. Thermo Fisher Scientific Recent Development
Table 43. Merck Company Information
Table 44. Merck Business Overview
Table 45. Merck Large-Scale Oligonucleotide Synthesis Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 46. Merck Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 47. Merck Recent Development
Table 48. Genscript Company Information
Table 49. Genscript Business Overview
Table 50. Genscript Large-Scale Oligonucleotide Synthesis Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 51. Genscript Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 52. Genscript Recent Development
Table 53. Guangzhou RiboBio Company Information
Table 54. Guangzhou RiboBio Business Overview
Table 55. Guangzhou RiboBio Large-Scale Oligonucleotide Synthesis Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. Guangzhou RiboBio Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 57. Guangzhou RiboBio Recent Development
Table 58. Tsingke Company Information
Table 59. Tsingke Business Overview
Table 60. Tsingke Large-Scale Oligonucleotide Synthesis Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 61. Tsingke Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 62. Tsingke Recent Development
Table 63. Abace Biotechnology Company Information
Table 64. Abace Biotechnology Business Overview
Table 65. Abace Biotechnology Large-Scale Oligonucleotide Synthesis Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 66. Abace Biotechnology Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 67. Abace Biotechnology Recent Development
Table 68. TriLink BioTechnologies Company Information
Table 69. TriLink BioTechnologies Business Overview
Table 70. TriLink BioTechnologies Large-Scale Oligonucleotide Synthesis Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. TriLink BioTechnologies Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 72. TriLink BioTechnologies Recent Development
Table 73. Synbio Technologies Company Information
Table 74. Synbio Technologies Business Overview
Table 75. Synbio Technologies Large-Scale Oligonucleotide Synthesis Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 76. Synbio Technologies Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 77. Synbio Technologies Recent Development
Table 78. Macrogen Company Information
Table 79. Macrogen Business Overview
Table 80. Macrogen Large-Scale Oligonucleotide Synthesis Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 81. Macrogen Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 82. Macrogen Recent Development
Table 83. Integrated DNA Technologies (IDT) Company Information
Table 84. Integrated DNA Technologies (IDT) Business Overview
Table 85. Integrated DNA Technologies (IDT) Large-Scale Oligonucleotide Synthesis Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 86. Integrated DNA Technologies (IDT) Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 87. Integrated DNA Technologies (IDT) Recent Development
Table 88. Eurogentec Company Information
Table 89. Eurogentec Business Overview
Table 90. Eurogentec Large-Scale Oligonucleotide Synthesis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. Eurogentec Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 92. Eurogentec Recent Development
Table 93. Cusabio Company Information
Table 94. Cusabio Business Overview
Table 95. Cusabio Large-Scale Oligonucleotide Synthesis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Cusabio Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 97. Cusabio Recent Development
Table 98. BBI Life Sciences Company Information
Table 99. BBI Life Sciences Business Overview
Table 100. BBI Life Sciences Large-Scale Oligonucleotide Synthesis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 101. BBI Life Sciences Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 102. BBI Life Sciences Recent Development
Table 103. Azenta Life Sciences Company Information
Table 104. Azenta Life Sciences Business Overview
Table 105. Azenta Life Sciences Large-Scale Oligonucleotide Synthesis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 106. Azenta Life Sciences Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 107. Azenta Life Sciences Recent Development
Table 108. Aurigene Pharmaceutical Services Company Information
Table 109. Aurigene Pharmaceutical Services Business Overview
Table 110. Aurigene Pharmaceutical Services Large-Scale Oligonucleotide Synthesis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 111. Aurigene Pharmaceutical Services Large-Scale Oligonucleotide Synthesis Services Product Portfolio
Table 112. Aurigene Pharmaceutical Services Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Authors List of This Report
Table 115. Secondary Sources
Table 116. Primary Sources
List of Figures
Figure 1. Large-Scale Oligonucleotide Synthesis Services Product Image
Figure 2. Global Large-Scale Oligonucleotide Synthesis Services Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Large-Scale Oligonucleotide Synthesis Services Market Size (2021-2032) & (US$ Million)
Figure 4. Global Large-Scale Oligonucleotide Synthesis Services Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Common Primer Synthesis Image
Figure 8. Modified Primer Synthesis Image
Figure 9. Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Share 2021 VS 2025 VS 2032
Figure 11. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type (2021-2032)
Figure 12. Biotech Company Image
Figure 13. Academic Scientific Research Institution Image
Figure 14. Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 15. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Share 2021 VS 2025 VS 2032
Figure 16. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application (2021-2032)
Figure 17. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 18. Global Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 19. North America Large-Scale Oligonucleotide Synthesis Services Sales Value (2021-2032) & (US$ Million)
Figure 20. North America Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Country (%), 2025 VS 2032
Figure 21. Europe Large-Scale Oligonucleotide Synthesis Services Sales Value (2021-2032) & (US$ Million)
Figure 22. Europe Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Country (%), 2025 VS 2032
Figure 23. Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Sales Value (2021-2032) & (US$ Million)
Figure 24. Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Country (%), 2025 VS 2032
Figure 25. South America Large-Scale Oligonucleotide Synthesis Services Sales Value (2021-2032) & (US$ Million)
Figure 26. South America Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Country (%), 2025 VS 2032
Figure 27. Middle East & Africa Large-Scale Oligonucleotide Synthesis Services Sales Value (2021-2032) & (US$ Million)
Figure 28. Middle East & Africa Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Country (%), 2025 VS 2032
Figure 29. USA Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 30. USA Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 31. USA Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 32. Canada Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 33. Canada Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 34. Canada Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 35. Mexico Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 36. Mexico Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 37. Mexico Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 38. Germany Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 39. Germany Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 40. Germany Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 41. France Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 42. France Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 43. France Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 44. U.K. Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 45. U.K. Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 46. U.K. Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 47. Italy Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 48. Italy Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 49. Italy Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 50. Spain Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 51. Spain Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 52. Spain Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 53. Russia Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 54. Russia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 55. Russia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 56. Netherlands Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 57. Netherlands Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 58. Netherlands Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 59. Nordic Countries Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 60. Nordic Countries Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 61. Nordic Countries Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 62. China Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 63. China Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 64. China Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 65. Japan Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 66. Japan Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 67. Japan Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 68. South Korea Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 69. South Korea Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 70. South Korea Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 71. India Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 72. India Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 73. India Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 74. Australia Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 75. Australia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 76. Australia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 77. Southeast Asia Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 78. Southeast Asia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 79. Southeast Asia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 80. Brazil Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 81. Brazil Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 82. Brazil Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 83. Argentina Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 84. Argentina Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 85. Argentina Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 86. Chile Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 87. Chile Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 88. Chile Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 89. Colombia Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 90. Colombia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 91. Colombia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 92. Peru Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 93. Peru Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 94. Peru Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 95. Saudi Arabia Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 96. Saudi Arabia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 97. Saudi Arabia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 98. Israel Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 99. Israel Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 100. Israel Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 101. UAE Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 102. UAE Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 103. UAE Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 104. Turkey Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 105. Turkey Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 106. Turkey Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 107. Iran Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 108. Iran Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 109. Iran Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 110. Egypt Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 111. Egypt Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 112. Egypt Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 113. Years Considered
Figure 114. Research Process
Figure 115. Key Executives Interviewed
Scope & coverage.
Types
- Common Primer Synthesis
- Modified Primer Synthesis
Applications
- Biotech Company
- Academic Scientific Research Institution
Companies covered
- Thermo Fisher Scientific
- Merck
- Genscript
- Guangzhou RiboBio
- Tsingke
- Abace Biotechnology
- TriLink BioTechnologies
- Synbio Technologies
- Macrogen
- Integrated DNA Technologies (IDT)
- Eurogentec
- Cusabio
- BBI Life Sciences
- Azenta Life Sciences
- Aurigene Pharmaceutical Services
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Large-Scale Oligonucleotide Synthesis Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Large-Scale Oligonucleotide Synthesis Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Large-Scale Oligonucleotide Synthesis Services Market Dynamics
- 2.1 Large-Scale Oligonucleotide Synthesis Services Industry Trends
- 2.2 Large-Scale Oligonucleotide Synthesis Services Industry Drivers
- 2.3 Large-Scale Oligonucleotide Synthesis Services Industry Opportunities and Challenges
- 2.4 Large-Scale Oligonucleotide Synthesis Services Industry Restraints
3 Large-Scale Oligonucleotide Synthesis Services Market by Company
- 3.1 Global Large-Scale Oligonucleotide Synthesis Services Company Revenue Ranking in 2025
- 3.2 Global Large-Scale Oligonucleotide Synthesis Services Revenue by Company (2021-2026)
- 3.3 Global Large-Scale Oligonucleotide Synthesis Services Company Ranking (2024-2026)
- 3.4 Global Large-Scale Oligonucleotide Synthesis Services Company Manufacturing Base and Headquarters
- 3.5 Global Large-Scale Oligonucleotide Synthesis Services Company Product Type and Application
- 3.6 Global Large-Scale Oligonucleotide Synthesis Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Large-Scale Oligonucleotide Synthesis Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Large-Scale Oligonucleotide Synthesis Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Large-Scale Oligonucleotide Synthesis Services Market by Type
- 4.1 Large-Scale Oligonucleotide Synthesis Services Type Introduction
- 4.1.1 Common Primer Synthesis
- 4.1.2 Modified Primer Synthesis
- 4.2 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Type
- 4.2.1 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Type (2021-2032)
- 4.2.3 Global Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type (2021-2032)
5 Large-Scale Oligonucleotide Synthesis Services Market by Application
- 5.1 Large-Scale Oligonucleotide Synthesis Services Application Introduction
- 5.1.1 Biotech Company
- 5.1.2 Academic Scientific Research Institution
- 5.2 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Application
- 5.2.1 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Application (2021-2032)
- 5.2.3 Global Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application (2021-2032)
6 Large-Scale Oligonucleotide Synthesis Services Regional Value Analysis
- 6.1 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Region (2021-2032)
- 6.2.1 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Region: 2021-2026
- 6.2.2 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Large-Scale Oligonucleotide Synthesis Services Sales Value (2021-2032)
- 6.3.2 North America Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Large-Scale Oligonucleotide Synthesis Services Sales Value (2021-2032)
- 6.4.2 Europe Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Large-Scale Oligonucleotide Synthesis Services Sales Value (2021-2032)
- 6.6.2 South America Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Large-Scale Oligonucleotide Synthesis Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Country, 2025 VS 2032
7 Large-Scale Oligonucleotide Synthesis Services Country-level Value Analysis
- 7.1 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Country (2021-2032)
- 7.2.1 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Country (2021-2026)
- 7.2.2 Global Large-Scale Oligonucleotide Synthesis Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Large-Scale Oligonucleotide Synthesis Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Large-Scale Oligonucleotide Synthesis Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Thermo Fisher Scientific
- 8.1.1 Thermo Fisher Scientific Company Information
- 8.1.2 Thermo Fisher Scientific Business Overview
- 8.1.3 Thermo Fisher Scientific Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Thermo Fisher Scientific Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.1.5 Thermo Fisher Scientific Recent Developments
- 8.2 Merck
- 8.2.1 Merck Company Information
- 8.2.2 Merck Business Overview
- 8.2.3 Merck Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.2.4 Merck Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.2.5 Merck Recent Developments
- 8.3 Genscript
- 8.3.1 Genscript Company Information
- 8.3.2 Genscript Business Overview
- 8.3.3 Genscript Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Genscript Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.3.5 Genscript Recent Developments
- 8.4 Guangzhou RiboBio
- 8.4.1 Guangzhou RiboBio Company Information
- 8.4.2 Guangzhou RiboBio Business Overview
- 8.4.3 Guangzhou RiboBio Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.4.4 Guangzhou RiboBio Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.4.5 Guangzhou RiboBio Recent Developments
- 8.5 Tsingke
- 8.5.1 Tsingke Company Information
- 8.5.2 Tsingke Business Overview
- 8.5.3 Tsingke Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Tsingke Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.5.5 Tsingke Recent Developments
- 8.6 Abace Biotechnology
- 8.6.1 Abace Biotechnology Company Information
- 8.6.2 Abace Biotechnology Business Overview
- 8.6.3 Abace Biotechnology Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.6.4 Abace Biotechnology Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.6.5 Abace Biotechnology Recent Developments
- 8.7 TriLink BioTechnologies
- 8.7.1 TriLink BioTechnologies Company Information
- 8.7.2 TriLink BioTechnologies Business Overview
- 8.7.3 TriLink BioTechnologies Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.7.4 TriLink BioTechnologies Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.7.5 TriLink BioTechnologies Recent Developments
- 8.8 Synbio Technologies
- 8.8.1 Synbio Technologies Company Information
- 8.8.2 Synbio Technologies Business Overview
- 8.8.3 Synbio Technologies Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Synbio Technologies Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.8.5 Synbio Technologies Recent Developments
- 8.9 Macrogen
- 8.9.1 Macrogen Company Information
- 8.9.2 Macrogen Business Overview
- 8.9.3 Macrogen Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Macrogen Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.9.5 Macrogen Recent Developments
- 8.10 Integrated DNA Technologies (IDT)
- 8.10.1 Integrated DNA Technologies (IDT) Company Information
- 8.10.2 Integrated DNA Technologies (IDT) Business Overview
- 8.10.3 Integrated DNA Technologies (IDT) Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.10.4 Integrated DNA Technologies (IDT) Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.10.5 Integrated DNA Technologies (IDT) Recent Developments
- 8.11 Eurogentec
- 8.11.1 Eurogentec Company Information
- 8.11.2 Eurogentec Business Overview
- 8.11.3 Eurogentec Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.11.4 Eurogentec Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.11.5 Eurogentec Recent Developments
- 8.12 Cusabio
- 8.12.1 Cusabio Company Information
- 8.12.2 Cusabio Business Overview
- 8.12.3 Cusabio Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.12.4 Cusabio Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.12.5 Cusabio Recent Developments
- 8.13 BBI Life Sciences
- 8.13.1 BBI Life Sciences Company Information
- 8.13.2 BBI Life Sciences Business Overview
- 8.13.3 BBI Life Sciences Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.13.4 BBI Life Sciences Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.13.5 BBI Life Sciences Recent Developments
- 8.14 Azenta Life Sciences
- 8.14.1 Azenta Life Sciences Company Information
- 8.14.2 Azenta Life Sciences Business Overview
- 8.14.3 Azenta Life Sciences Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.14.4 Azenta Life Sciences Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.14.5 Azenta Life Sciences Recent Developments
- 8.15 Aurigene Pharmaceutical Services
- 8.15.1 Aurigene Pharmaceutical Services Company Information
- 8.15.2 Aurigene Pharmaceutical Services Business Overview
- 8.15.3 Aurigene Pharmaceutical Services Large-Scale Oligonucleotide Synthesis Services Revenue and Gross Margin (2021-2026)
- 8.15.4 Aurigene Pharmaceutical Services Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 8.15.5 Aurigene Pharmaceutical Services Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst